New AI-Based Medical Image Segmentation and Measurement Tool Minimizes Human Errors in Clinical Analysis
|
By MedImaging International staff writers Posted on 21 Jan 2021 |

Image: New AI-Based Medical Image Segmentation and Measurement Tool Minimizes Human Errors in Clinical Analysis (Photo courtesy of Business Wire)
A new general purpose, AI-based medical image segmentation and measurement tool for detecting objects of interest and their boundaries quickly and automatically could make surgical and diagnostic measurements easier and more accurate for better treatment decisions.
RSIP Vision (Jerusalem, Israel) has launched the AI-based solution that requires minimal work by the user to deliver an accurate 3D visualization and analysis of patient anatomy and is applicable across medical imaging verticals & modalities. The solution runs automatically and is robust and clinically accurate, avoiding human factors such as fatigue and misreads which may result in mistakes in measurement.
RSIP Vision is offering the AI-based software to medical device manufacturers for use in leading facilities worldwide in order to detect and localize the area of interest and use those complex features in a scan through a series of algorithms. The segmentation creates boundaries around the image for better viewing and performs automatic measurements. Physicians and researchers can receive consistent, repeatable measurements regarding the dimensions and characteristics of a specific area, using AI technology that is available across all modalities, including X-ray, CT scans, MR, surgical robotics, and pathology. For example, the tool can be used for one-click segmentation of lesions in multiple organs such as the lungs and the liver, across patient populations and cohorts. The new AI module can be easily integrated in medical device software for multiple applications, without the need to collect and train machine learning models on extensive domain-specific training data, accelerating time to market for medical device companies looking to stay ahead of the AI adoption curve.
“Distinguishing and measuring organs, lesions, and other areas of interest in biopsy and pre-surgical planning can be tedious work, which is generally assigned to a specific employee or technician, or even a physician,” said Ron Soferman, Founder & CEO at RSIP Vision. “Our new segmentation tool makes it easier to pinpoint specific points and boundaries in images, which in turn leads to greater accuracy during surgeries without being dependent on the capability and experience of a specific individual. In 2021, RSIP Vision will continue to drive innovation in image analysis across the medical verticals through custom software, advanced algorithm development and custom technologies which will be found in medical devices in leading facilities worldwide. RSIP Vision ensures customers can leverage the latest advances in AI and computer vision, in order to save time and cost during medical procedures.”
Related Links:
RSIP Vision
RSIP Vision (Jerusalem, Israel) has launched the AI-based solution that requires minimal work by the user to deliver an accurate 3D visualization and analysis of patient anatomy and is applicable across medical imaging verticals & modalities. The solution runs automatically and is robust and clinically accurate, avoiding human factors such as fatigue and misreads which may result in mistakes in measurement.
RSIP Vision is offering the AI-based software to medical device manufacturers for use in leading facilities worldwide in order to detect and localize the area of interest and use those complex features in a scan through a series of algorithms. The segmentation creates boundaries around the image for better viewing and performs automatic measurements. Physicians and researchers can receive consistent, repeatable measurements regarding the dimensions and characteristics of a specific area, using AI technology that is available across all modalities, including X-ray, CT scans, MR, surgical robotics, and pathology. For example, the tool can be used for one-click segmentation of lesions in multiple organs such as the lungs and the liver, across patient populations and cohorts. The new AI module can be easily integrated in medical device software for multiple applications, without the need to collect and train machine learning models on extensive domain-specific training data, accelerating time to market for medical device companies looking to stay ahead of the AI adoption curve.
“Distinguishing and measuring organs, lesions, and other areas of interest in biopsy and pre-surgical planning can be tedious work, which is generally assigned to a specific employee or technician, or even a physician,” said Ron Soferman, Founder & CEO at RSIP Vision. “Our new segmentation tool makes it easier to pinpoint specific points and boundaries in images, which in turn leads to greater accuracy during surgeries without being dependent on the capability and experience of a specific individual. In 2021, RSIP Vision will continue to drive innovation in image analysis across the medical verticals through custom software, advanced algorithm development and custom technologies which will be found in medical devices in leading facilities worldwide. RSIP Vision ensures customers can leverage the latest advances in AI and computer vision, in order to save time and cost during medical procedures.”
Related Links:
RSIP Vision
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
Precise localization of small and deep brain structures remains a hurdle for radiology and neurosurgical planning. Limited resolution in many magnetic resonance imaging atlases constrains segmentation... Read more
Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Many men with suspected prostate cancer face an invasive biopsy when magnetic resonance imaging (MRI) is inconclusive. Biopsies can be uncomfortable, carry risks, and may contribute to overdiagnosis and... Read moreUltrasound
view channel
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







